Hoth Therapeutics, Inc.
HOTH
$1.20
$0.065.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.19M | 4.98M | 4.90M | 4.97M | 4.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.14M | 10.29M | 9.81M | 8.50M | 8.07M |
| Operating Income | -12.14M | -10.29M | -9.81M | -8.50M | -8.07M |
| Income Before Tax | -12.16M | -10.29M | -9.80M | -8.47M | -8.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.16 | -10.29 | -9.80 | -8.47 | -8.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.16M | -10.29M | -9.80M | -8.47M | -8.05M |
| EBIT | -12.14M | -10.29M | -9.81M | -8.50M | -8.07M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.06 | -1.09 | -1.17 | -1.39 | -1.51 |
| Normalized Basic EPS | -0.66 | -0.68 | -0.73 | -0.87 | -0.94 |
| EPS Diluted | -1.06 | -1.09 | -1.17 | -1.39 | -1.51 |
| Normalized Diluted EPS | -0.66 | -0.68 | -0.73 | -0.87 | -0.94 |
| Average Basic Shares Outstanding | 47.01M | 40.12M | 33.82M | 25.49M | 22.54M |
| Average Diluted Shares Outstanding | 47.01M | 40.12M | 33.82M | 25.49M | 22.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |